Home » D Pharm Reports Stroke Treatment Safety Approval
D Pharm Reports Stroke Treatment Safety Approval
D Pharm reported the Data and Safety Monitoring Board recommends the company’s ischemic stroke treatment DP-b99 after it proved safe in a Phase III clinical trial.
Globes
Globes
Upcoming Events
-
07May
-
14May
-
30May